2190 — Zylox-Tonbridge Medical Technology Co Share Price
0.000.00%
Last trade - 00:00- HK$11.87bn
- HK$10.60bn
- CNY782.48m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 32.15 | ||
| PEG Ratio (f) | 0.97 | ||
| EPS Growth (f) | 49.77% | ||
| Dividend Yield (f) | 0.3% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.61 | ||
| Price to Tang. Book | 3.64 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 14.31 | ||
| EV to EBITDA | 276.52 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.16% | ||
| Return on Equity | 3.26% | ||
| Operating Margin | 4.62% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 27.63 | 177.91 | 334.09 | 527.75 | 782.48 | 1,068.31 | 1,399.49 | 175.65% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | +53.09 | +45.26 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Zylox-Tonbridge Medical Technology Co Ltd is a China-based company mainly engaged in the manufacture of neurological and peripheral vascular interventional devices. The Company's main business is to provide medical devices for the treatment and treatment of neurological and peripheral vascular diseases for doctors and patients. The main products are Phoenix Neurovascular Embolization Coil, Thrombite Clot Retriever Device, White Horse Intracranial Balloon Catheter, as well as UltraFree Drug-coated PTA Balloon Catheter, ZENFLOW PTA Balloon Catheter and ZENFLOW High Pressure PTA Balloon Catheter.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 6th, 2012
- Public Since
- July 5th, 2021
- No. of Employees
- 875
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 641,591,770
- Address
- 270 Shuyun Road, HANGZHOU
- Web
- https://www.zyloxtb.com/
- Phone
- +86 57188610082
- Auditors
- PricewaterhouseCoopers
Upcoming Events for 2190
Zylox-Tonbridge Medical Technology Co Ltd Annual Shareholders Meeting
Similar to 2190
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the Zylox-Tonbridge Medical Technology Co share price?
As of Today at 24:17 UTC, shares in Zylox-Tonbridge Medical Technology Co are trading at HK$18.58. This share price information is delayed by 15 minutes.
How has the Zylox-Tonbridge Medical Technology Co share price performed this year?
Shares in Zylox-Tonbridge Medical Technology Co last closed at HK$18.58 and the price had moved by +81.45% over the past 365 days. In terms of relative price strength the Zylox-Tonbridge Medical Technology Co share price has outperformed the FTSE Developed Asia Pacific Index by +83.52% over the past year.
What are the analyst and broker recommendations for Zylox-Tonbridge Medical Technology Co?
The overall consensus recommendation for Zylox-Tonbridge Medical Technology Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Zylox-Tonbridge Medical Technology Co dividend yield?
Zylox-Tonbridge Medical Technology Co does not currently pay a dividend.
Does Zylox-Tonbridge Medical Technology Co pay a dividend?
Zylox-Tonbridge Medical Technology Co does not currently pay a dividend.
When does Zylox-Tonbridge Medical Technology Co next pay dividends?
Zylox-Tonbridge Medical Technology Co does not currently pay a dividend.
How do I buy Zylox-Tonbridge Medical Technology Co shares?
To buy shares in Zylox-Tonbridge Medical Technology Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Zylox-Tonbridge Medical Technology Co?
As of the previous close price of HK$18.58, shares in Zylox-Tonbridge Medical Technology Co had a market capitalisation of HK$11.87bn.
Where are Zylox-Tonbridge Medical Technology Co shares listed?
Here are the trading details for Zylox-Tonbridge Medical Technology Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2190
What kind of share is Zylox-Tonbridge Medical Technology Co?
Based on an overall assessment of its quality, value and momentum Zylox-Tonbridge Medical Technology Co is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Zylox-Tonbridge Medical Technology Co share price forecast for 2025?
The analyst consensus target price for shares in Zylox-Tonbridge Medical Technology Co is HK$18.87. That is 1.55% above the last closing price of HK$18.58.
Analysts covering Zylox-Tonbridge Medical Technology Co currently have a consensus Earnings Per Share (EPS) forecast of CNY0.47 for the next financial year.
Find out moreWhat is the trend in the Zylox-Tonbridge Medical Technology Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zylox-Tonbridge Medical Technology Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +62.71%.
As of the last closing price of HK$18.58, shares in Zylox-Tonbridge Medical Technology Co were trading +53.08% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Zylox-Tonbridge Medical Technology Co PE Ratio?
The Zylox-Tonbridge Medical Technology Co PE ratio based on its reported earnings over the past 12 months is 32.15. The shares last closed at HK$18.58.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Zylox-Tonbridge Medical Technology Co?
We do not have data on Zylox-Tonbridge Medical Technology Co's directors